Amedeo's Top 20

Amedeo Smart

Independent Medical Education

01 September 2014

Multidisciplinary Journal Club

  1. Diacon AH, Pym A, Grobusch MP, de los Rios JM, et al.
    Multidrug-resistant tuberculosis and culture conversion with bedaquiline.
    N Engl J Med 2014;371:723-32.

  1. Michaleff ZA, Maher CG, Lin CW, Rebbeck T, et al.
    Comprehensive physiotherapy exercise programme or advice for chronic whiplash (PROMISE): a pragmatic randomised controlled trial.
    Lancet 2014;384:133-41.

  2. Le Roux P, Menon DK, Citerio G, Vespa P, et al.
    Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care : A statement for healthcare professionals from the Neurocritical Care Society and the European Society o
    Intensive Care Med 2014.

  3. Paquette SG, Banner D, Chi le TB, Leomicronn AJ, et al.
    Pandemic H1N1 influenza A directly induces a robust and acute inflammatory gene signature in primary human bronchial epithelial cells downstream of membrane fusion.
    Virology 2014;448:91-103.

  4. Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, et al.
    Association of urinary sodium and potassium excretion with blood pressure.
    N Engl J Med 2014;371:601-11.

  1. Bittenbring JT, Neumann F, Altmann B, Achenbach M, et al.
    Vitamin D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With but Not Without Rituximab.
    J Clin Oncol 2014.

  2. Mason E, McDougall L, Lawn JE, Gupta A, et al.
    From evidence to action to deliver a healthy start for the next generation.
    Lancet 2014;384:455-67.

  3. Rader DJ, Hovingh GK.
    HDL and cardiovascular disease.
    Lancet 2014;384:618-25.

  4. Hohmann EL, Ananthakrishnan AN, Deshpande V.
    Case Records of the Massachusetts General Hospital. Case 25-2014. A 37-year-old man with ulcerative colitis and bloody diarrhea.
    N Engl J Med 2014;371:668-75.

  5. Prat A, Carey LA, Adamo B, Vidal M, et al.
    Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer.
    J Natl Cancer Inst 2014;106.

  1. Nowakowski GS, LaPlant B, Macon WR, Reeder CB, et al.
    Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non-Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study.
    J Clin Oncol 2014.

  2. Nordestgaard BG, Varbo A.
    Triglycerides and cardiovascular disease.
    Lancet 2014;384:626-35.

  3. Myles PS, Leslie K, Chan MT, Forbes A, et al.
    The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial.
    Lancet 2014.

  4. Levesque BG, Sandborn WJ, Ruel J, Feagan BG, et al.
    Converging Goals of Treatment for Inflammatory Bowel Disease, from Clinical Trials and Practice.
    Gastroenterology 2014.

  5. de la Riva P, Smith K, Xie SX, Weintraub D, et al.
    Course of psychiatric symptoms and global cognition in early Parkinson disease.
    Neurology 2014.

  1. Di Biase L, Burkhardt D, Santangeli P, Mohanty P, et al.
    Periprocedural Stroke and Bleeding Complications in Patients undergoing Catheter Ablation of Atrial Fibrillation with Different Anticoagulation Management: Results from the "COMPARE" Randomized Trial.
    Circulation 2014.

  2. Sundstrom J, Arima H, Woodward M, Jackson R, et al.
    Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.
    Lancet 2014;384:591-8.

  3. Venderbosch S, Nagtegaal ID, Maughan TS, Smith CG, et al.
    Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN and FOCUS studies.
    Clin Cancer Res 2014.

  4. Paschou P, Drineas P, Yannaki E, Razou A, et al.
    Maritime route of colonization of Europe.
    Proc Natl Acad Sci U S A 2014;111:9211-6.

  5. Rice AS, Dworkin RH, McCarthy TD, Anand P, et al.
    EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
    Lancet 2014;383:1637-47.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016